sildenafil
The safety of sildenafil has been shown to be       satisfactory in clinical trials: in particular, the risk of myocardial infarction       is no greater in treated patients.
The safety of  @SUBJECT$  has been shown to be       satisfactory in clinical trials: in particular, the  @PREDICAT$  of  @OBJECT$        is no greater in treated patients.